Roger Dansey

Roger Dansey

Director/Board Member at INOVIO PHARMACEUTICALS, INC.

Net worth: 49 732 $ as of 2024-03-30

68 year
Health Technology
Consumer Services

Profile

Presently, Roger D. Dansey occupies the position of Chief Medical Officer for Seagen Inc. In the past Dr. Dansey held the position of Vice President-Oncology Clinical Research at Gilead Sciences, Inc. and SVP & Head-Therapeutic Area at Merck Research Laboratories Massachusetts LLC. Dr. Dansey received a doctorate from the University of the Witwatersrand.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-11-15 3,583 ( 0.02% ) 49 732 $ 2024-03-30

Roger Dansey active positions

CompaniesPositionStart
INOVIO PHARMACEUTICALS, INC. Director/Board Member 2021-05-12
KRONOS BIO, INC. Director/Board Member 2023-04-19
All active positions of Roger Dansey

Former positions of Roger Dansey

CompaniesPositionEnd
SEAGEN INC. Chief Executive Officer 2022-11-08
Corporate Officer/Principal 2018-03-31
MERCK & CO., INC. Corporate Officer/Principal 2018-03-31
GILEAD SCIENCES, INC. Corporate Officer/Principal 2013-12-31
See the detail of Roger Dansey's experience

Training of Roger Dansey

University of the Witwatersrand Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Roger Dansey's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
GILEAD SCIENCES, INC.

Health Technology

MERCK & CO., INC.

Health Technology

INOVIO PHARMACEUTICALS, INC.

Health Technology

KRONOS BIO, INC.

Health Technology

Private companies2

Health Technology

Health Technology

See company connections